Debut Plus

19.4

+1.1 +6.01%

17 Jul 2026

NSE Listed

Medistep Healthcare Ltd. (MEDISTEP)

Volume: 6,000Avg Vol 1W: 3,000Avg Vol 1M: 5,10052W Range:16.553
Key Ratios
Checked 6h ago
Market Cap₹26 Cr
Current Price₹19.4
Previous Close₹18.3
High / Low (52w)₹53 / ₹16.5
Volume6,000
Avg Vol (1W)3,000
Avg Vol (1M)5,100
Stock P/E4.35
Book Value₹26.62
Dividend Yield0%
ROE15.82%
ROA0%
Revenue (TTM)₹50 Cr
Revenue Growth
Profit Margin0%
Total Debt
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹4.21
P/B0.69
Debt / Equity0.03
50 DMA₹19.77
200 DMA₹24.83
Day change+6.01%
Price Chart
19.4 61.47% · 1Y
501715.3L
2025-08-18
2026-07-16

20-day avg volume: 5K shares

Pros
  • Healthy return on equity of 15.8%.
  • Company is almost debt-free.
  • Stock trades below its book value.
Cons
  • Revenue fell 36% YoY.
Quarterly Results
MetricJun 2024
Revenue₹11 Cr
EBITDA₹1 Cr
Net Profit₹1 Cr
EPS
Profit & Loss (Annual)
MetricMar 2024Mar 2025
Revenue₹32 Cr₹50 Cr
EBITDA₹4 Cr₹6 Cr
Net Profit₹3 Cr₹4 Cr
EPS19.964.01
Balance Sheet
MetricMar 2024Mar 2025
Total Assets₹15 Cr₹23 Cr
Total Liabilities₹3 Cr₹6 Cr
Equity₹12 Cr₹17 Cr
Total Debt
Cash Flow
MetricMar 2024Mar 2025
Operating₹-7 Cr₹0 Cr
Investing₹0 Cr₹0 Cr
Financing₹7 Cr₹1 Cr
Free Cash Flow₹-7 Cr₹0 Cr
Shareholding
Promoter 68.96% Institutions 0% Public 31.04%
Efficiency & Working Capital
ROCE19.2%
Interest Coverage139.3
Dividend Payout
Debtor Days148 d
Inventory Days8 d
Payable Days18 d
Cash Conversion Cycle138 d
Working Capital Days156 d
Shareholding Details

As of 2026-03-31

Promoter69%
FII0%
DII0%
Institutions0%
Public31%
Promoter Pledge0%
No. of Shareholders514
Shareholding Pattern

Quarterly — figures in %. Latest 5 quarters.

PeriodDec 2024Aug 2025Aug 2025Sept 2025Mar 2026
Promoters93.6%69%69%69%69%
FIIs0%0%0%0%0%
DIIs0%0%0%0%0%
Public6.4%31%31%31%31%
Promoter Pledge0%0%0%0%0%
No. of Shareholders8525525578514
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Prajapati Hetalben ShankarlalShareholding of Promoter and Promoter Group50.1%71,16,400
Girdharilal PrajapatShareholding of Promoter and Promoter Group9.9%14,11,800
Vipul Gobarbhai DabhiShareholding of Promoter and Promoter Group8.9%12,69,880
Nitin Singh BhatiPublic Shareholding4.7%6,66,666
Vijith Narayanan MenonPublic Shareholding2.6%3,69,000
Tirulekha Biosciences Private LimitedPublic Shareholding1.9%2,76,000
Babitha MenonPublic Shareholding1.8%2,55,000
Dharmishthaben Vipulbhai DabhiShareholding of Promoter and Promoter Group0%200
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Prajapati Hetalben Shankarlal00%2026-03-31
Girdharilal Prajapat00%2026-03-31
Vipul Gobarbhai Dabhi00%2026-03-31
Dharmishthaben Vipulbhai Dabhi00%2026-03-31
Nitin Singh Bhati00%2026-03-31
Vijith Narayanan Menon00%2026-03-31
Babitha Menon00%2026-03-31
Tirulekha Biosciences Private Limited00%2026-03-31
Prajapati Hetalben Shankarlal00%2025-09-30
Girdharilal Prajapat00%2025-09-30
Vipul Gobarbhai Dabhi00%2025-09-30
Dharmishthaben Vipulbhai Dabhi00%2025-09-30
Board of Directors
NameDesignationYear
Girdhari Lal PrajapatManaging Director2025
Vipul Gobarbhai DabhiExecutive Director2025
Hetalben Girdharilal PrajapatiNon Executive Director2025
Anandbhai Jitendrabhai KhodaIndependent Non Exe. Director2025
Kapilbhai Raysinhbhai DodiyaIndependent Non Exe. Director2025
Sashikala BhutraCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Manufacturing segment₹13 Cr26.5%
Trading₹36 Cr73.5%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10151010
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000166
2025000101
2025000000
Company Information
Incorporated2023
AuditorMukesh Mishra & Associates
Investor Email[email protected]
🌐 www.medistephc.com

📍 05 S.#-245/B Plot-19 T.P.S.56, Free Way Trade Center Narol, Ahmedabad, Gujarat, 382405

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search